The STAR*D trial is the largest and most consequential antidepressant study
|
|
- Christian Chambers
- 6 years ago
- Views:
Transcription
1 CnJPsychitry 2015;60(1):9 13 Perspective The STAR*D Tril: It Is Time to Reexmine the Clinicl Beliefs Tht Guide the Tretment of Mjor Depression H Edmund Pigott, PhD 1 1 Chief Clinicl Officer, Positive Brin Trining, LLC, Juno Bech, Florid; Psychologist, Guiding Light Wellness Center, Wellington, Florid. Correspondence: 430 North Lyr Circle, Juno Bech, FL 33408; pthwre@erols.com. Key Words: depression, Sequenced Tretment Alterntives to Relieve Depression, STAR*D, selective outcome reporting Received June 2014, revised, nd ccepted July The STAR*D tril is the lrgest nd most consequentil ntidepressnt study ever conducted, with over 120 journl rticles published by study investigtors, innumerble cittions of STAR*D s findings by other reserchers, nd extensive coverge in the medi, thereby giving it n oversized impct on the tretment of depression, worldwide. Funded t cost of 35-million US dollrs, STAR*D enrolled 4041 ptients who screened positive for mjor depression while seeking routine medicl or psychitric cre. In contrst to most industry-funded trils, STAR*D included depressed ptients with comorbid conditions, thereby incresing the generlizbility of its findings nd further, provided 12 months of free continuing cre to monitor the durbility of tretment effects. STAR*D provided up to 4 tretment steps per ptient nd ws designed to give guidnce in selecting the best next-step tretment for the mny ptients who fil to get sufficient relief from their initil AD. Ech step consisted of 12-week, open-lbel tril, with n dditionl 2 weeks for ptients deemed close to remission. ADs were dministered using system of mesurement-bsed cre tht involved ssessing symptoms nd side effects t ech visit to guide ggressive mediction dosing to ensure tht the likelihood of chieving remission ws mximized nd tht those who did not rech remission were 1, p 30 truly resistnt to the mediction. STAR*D llowed ptients to select tretment options for rndomiztion in steps 2 to 4 to empower ptients, strengthen the therpeutic llince, optimize tretment dherence, nd improve outcome 2, p 483 nd evluted the reltive effectiveness of 11 phrmcologiclly distinct drug drug combintion tretments in 5 hed-to-hed comprisons. CT ws lso vilble s switch or drug ugmenttion option in step 2, but too few ptients included it s n cceptble tretment, resulting in only 101 contributing dt fter rndomiztion. Therefore, CT ws excluded from the step 2 switch nd ugmenttion nlyses. 3,4 Ptients who chieved remission during ny step were encourged to enter the 12 months of free follow-up cre, s were responder ptients who filed to ttin remission but did not wnt to continue to the next tretment step s this would involve chnge in mediction. Remission ws defined s score of less thn 8 on the HRSD, the study s prespecified primry outcome mesure, nd response s 50% or greter reduction in depressive symptoms on it. The follow-up protocol strongly recommended tht prticipnts continue the previously effective cute tretment mediction(s) t the doses used in cute tretment but treting physicins were llowed to mke ny psychotherpy, mediction, or mediction dose chnge 5, p 1908 they deemed necessry to sustin positive outcome during follow-up, including scheduling dditionl visits if depressive symptoms returned nd (or) intolerble side effects emerged. 6 The Cndin Journl of Psychitry, Vol 60, No 1, Jnury 2015 W 9
2 Perspective Prior Criticisms of Apprent Bis in the Reporting of STAR*D Findings Pigott nd collegues 7,8 hve previously criticized the investigtors for the following: 1) not reporting in their summry rticle 5 remission nd response rtes using the prespecified HRSD but insted using the QIDS-SR, nonblinded, clinic-dministered ssessment tht ws excluded from use s reserch mesure in the Reserch Protocol 9 ; 2) excluding from nlysis ptients who strted on citloprm in their bseline visit nd then dropped out without tking the exit HRSD despite the investigtors sttement tht our primry nlyses clssified ptients with missing exit HRSD scores s nonremitters priori 1, p 43 nd these erly dropout ptients therefore should hve been counted s tretment filures s prespecified; 3) sserting in their summry rticle theoreticl cumultive remission rte of 67% with the unrelistic provisos tht this estimte ssumes no dropouts, nd it ssumes tht those who exited the study would hve hd the sme remission rtes s those who styed in the protocol 5, p 1910 ; nd 4) other indictors of bis (see etble 1). As Pigott et l 7 document, the investigtors ssumptions in clculting their theoreticl remission rte of 67% re simply not true in the rel world, nd were certinly not true in STAR*D, s more ptients dropped out in ech step thn remitted. Tody, STAR*D investigtors provisos concerning their theoreticl remission rte re sometimes dropped when portrying its findings. For exmple, recent editoril in the AJP sttes STAR*D found, fter four optimized, well-delivered tretments, pproximtely 70% of ptients chieve remission 10, p 580 s though this is fctul sttement of wht occurred. Figure 7 in STAR*D s Reserch Protocol hs step-bystep predictions of ptient drop out nd the number of ptients who would hve stisfctory response nd enter follow-up. 9, p 35 The Protocol ws obtined from NIMH in Abbrevitions AD ntidepressnt AJP Americn Journl of Psychitry CCJM Clevelnd Clinic Journl of Medicine CT cognitive therpy HRSD Hmilton Rting Scle for Depression NIMH Ntionl Institute of Mentl Helth PCP primry cre physicin QIDS-SR Quick Inventory of Depressive Symptoms Self Report RCT rndomized controlled tril STAR*D Sequenced Tretment Alterntives to Relieve Depression 10 W L Revue cndienne de psychitrie, vol 60, no 1, jnvier 2015 Freedom of Informtion Act request. The predictions reflect the predicted ggregte outcomes for STAR*D s sequentil tret-to-remission model of mesurement-bsed cre. STAR*D s investigtors found no significnt group differences between ny of the 11 drug drug combintion tretments. Further, no post hoc secondry nlyses hve reported significnt predictors of outcomes between the phrmcologiclly distinct tretments. Therefore, STAR*D provides no next-step guidnce to give hope for improving outcomes beyond tht found in the study itself. As Brbui et l 11 note, AD study completion rtes provide hrd mesure of tretment effectiveness nd cceptbility p 296 nd STAR*D s investigtors essentilly ignore this fct when reporting study outcomes. Elsewhere, Pigott 8 hs detiled the extensive efforts STAR*D mde to keep ptients in tretment nd mximize their likelihood of chieving remission nd mintining it during the 12 months of follow-up cre s well s completing the scheduled reserch ssessments; thus it is essentil to incorporte dropout ptients into the evlution of study outcomes. Methods The uthor bstrcted from the Reserch Protocol nd summry rticle s 5 published tbles nd figures to reclculte STAR*D s remission nd relpse rtes using 4041 s the denomintor, s ll ptients were strted on citloprm in their bseline visit. This pproch seems more relistic thn the summry rticle 5 tht used 3671 s the denomintor, thereby excluding from nlysis the 370 erly dropout ptients who did not return for subsequent tretment visits. The Dt Figure 1 compres the cumultive step-by-step predicted per cent of ptients who would be successfully treted nd enter follow-up nd STAR*D s theoreticl remission rte to wht occurred in the study. In the summry rticle, 5 STAR*D s reserchers used the nonblinded QIDS-SR to report cute nd follow-up cre outcomes insted of the protocol-specified HRSD. This ssessment ws dministered t ech clinic visit nd monthly by telephone during follow-up. The QIDS-SR provided more complete dt set s 690 ptients exited the study in step 1 lone, without tking the exit HRSD, 152 of whom hd QIDS-SR defined remission. 1, p 34 The cumultive per cent of ptients who hd remission determined by their finl QIDS-SR fter up to 4 tretment trils ws 45.9%. By step 4, the cumultive per cent of such ptients who entered follow-up ws only 37.6%. While both clcultions used 4041 s the denomintor, these findings improve little when using 3671 ptients s the denomintor (50.5% nd 41.4%, respectively). The dt STAR*D investigtors provide for ccessing the durbility of tretment gins re even more discourging. For step 1, only 17.8% of citloprm-treted ptients hd remission s determined by their lst clinic-dministered
3 The STAR*D Tril: It Is Time to Reexmine the Clinicl Beliefs Tht Guide the Tretment of Mjor Depression Figure 1 Comprison between predicted, theoreticl, nd ctul step-by-step success rtes Predicted % to enter follow -up 60 Theoreticl remission rteb Rte, % c Remitted ptients determined by lst QIDS-SR who entered follow-up d Remitted ptients e Remitted ptients without confirmed relpse 10 Without relpse nd (or) drop out f 0 Step 1 Step 2 Step 3 Step 4 Step Clculted from Figure 7 in STAR*D s Reserch Protocol predicting how mny ptients would hve stisfctory response nd enter follow-up. b Clculted by STAR*D s uthors in the summry rticle. 5 c Clculted from the summry rticle s Tble 3 Remission t ech step row but using 4041 s the denomintor s ll ptients were strted on citloprm in their bseline visit (tht is, ( )/4041 = 45.9% by step 4). d Clculted from the summry rticle s Tble 5, column 2, rows 3, 6, 9, nd 12, by dding the number of remitted ptients entering follow-up nd dividing by 4041 (tht is, ( )/4041 = 37.6% by step 4). e Clculted from the summry rticle s Tble 5, column 6, rows 3, 6, 9, nd 12. For ech step, subtrct the per cent relpse rte from 1.0 nd then mulitply by the number of remitted ptients entering follow-up (for exmple, step 1: = x 1085 = 722 remitted ptients who did not hve confirmed relpse during follow-up). Repet for steps 2 to 4. Add the remitted ptients without confirmed relpse for steps 1 to 4 nd divide by f Clculted from the summry rticle Figure 3 s tble, column 5, by dding the number of surviving remitted ptients without relpse nd (or) drop out during months 10 to 12 nd dividing by 4041 (tht is, ( )/4041 = 2.7% by step 4). QIDS-SR = Quick Inventory of Depressive Symptoms Self Report; STAR*D = Sequenced Tretment Alterntives to Relieve Depression QIDS-SR nd during follow-up did not hve confirmed relpse on 1 or more of the 12 monthly dministered telephonic QIDS-SR ssessments. After up to 4 rounds of AD drug drug combintion tretments, the cumultive rte of ptients who did not hve confirmed relpse improved to only 23.5%. When drop out is dded, the durbility of tretment effects is even pltrier. Only 2.7% of ptients hd QIDS-SR determined remission fter up to 4 rounds of AD drug cre nd neither relpsed nor dropped out s evidenced by tking t lest 1 of the months 10-to-12 QIDS-SR telephonic ssessments nd not scoring s hving relpsed in ny of the 12 monthly dministered ssessments. Figure 2 presents the rtes of intolerble side effects nd drop out by tretment step tken from the summry rticle s 5 Tble 3 nd Figure 1. It demonstrtes how ech chnge in tretment resulted in n incresed rte of intolerble side effects from the newly prescribed mediction, compred with the prior step, incresing from 16.3% in step 1 to 30.1% by step 4. This sme trend is seen for study drop out, with it incresing from 28.1% in step 1 to 42.3% by step 3. Both mesures demonstrte n incresing risk to ptient cre tied to ech chnge in AD drug drug combintion tretment s ptients progressed from step 1 through steps 2 to 4. The Need for Reexmintion Following publiction of STAR*D s steps 1 to 4 nd summry results in 2006, 1 5,12 14 its investigtors hve continued publishing t high rte of over 120 journl rticles, including the recent AJP one which precipitted the editoril cited bove. 15 In ddition to not disclosing devitions from the prespecified criteri, often in these rticles the investigtors interpret wht they do report in wys tht led to inccurte conclusions nd potentilly hrmful recommendtions for ptient cre. For exmple, in their CCJM rticle s Key Points section, the investigtors stte: With persistent nd vigorous tretment, most ptients will enter remission: bout 33% fter one step, 50% fter two steps, 60% fter three steps, nd 70% fter four steps (ssuming ptients sty in 16, p 57 tretment). The investigtors then open this rticle stting: DEPRESSION cn be treted successfully by primry cre physicins under rel world conditions. Furthermore, the prticulr drug or drugs used re not s importnt s following rtionl pln: giving ntidepressnt medictions in dequte The Cndin Journl of Psychitry, Vol 60, No 1, Jnury 2015 W 11
4 Perspective Figure 2 Rtes of intolerble side effects nd drop out by tretment step Rte, % Intolerble side effects Study drop out b 0 Step 1 Step 2 Step 3 Step 4 Step From the Intolerble side effects row, Tble 3, of the summry rticle. 5 b Clculted from Figure 1 by dding ll ptients who exited the study in steps 1 to 3 nd dividing by the number enrolled in ech step. doses, monitoring the ptient s symptoms nd side effects nd djusting the regimen ccordingly, nd switching drugs or dding new drugs to the regimen only fter n dequte tril. These re mong the lessons lerned from the Sequenced Tretment Alterntives to Relieve Depression study, the lrgest prospective clinicl tril of tretment of mjor 16, p 57 depressive disorder ever conducted. There re severl noteworthy points in this rticle s summry of STAR*D s lessons lerned for PCPs who prescribe most ADs. First when summrizing their results, the highly theoreticl 67% remission rte is rounded up to 70%. Second, the summry rticle s proviso tht this rte ssumes tht those who exited the study would hve hd the sme remission rtes s those who styed in the protocol 5, p 1910 is dropped, leving only the ssumption of no dropouts. Third, nowhere in this rticle nor elsewhere do the investigtors cknowledge tht through step 3, 43% of ptients hd in fct dropped out despite their best efforts in designing the study so s to minimize this hrd mesure of tretment (in)effectiveness 11, p 296 from occurring. Fourth, while correctly stting tht the prticulr drug or drugs used re not s importnt 16, p 57 s STAR*D provides no next-step guidnce to improve outcomes, the investigtors strongly endorse here s elsewhere their system of mesurement-bsed cre s the mens to improve sid outcomes. For exmple, the investigtors stte: high qulity of cre ws delivered (mesurementbsed cre)... Consequently, the outcomes in this report my exceed those tht re presently obtined in dily prctice wherein neither symptoms nor 12 W L Revue cndienne de psychitrie, vol 60, no 1, jnvier 2015 side-effects re consistently mesured nd wherein prctitioners vry gretly in the timing nd level of 5, p 1914 dosing [emphses dded]. As Pigott et l 7 noted, STAR*D s sequentil tret-toremission model of mesurement-bsed cre my hve been detrimentl to ptient cre leding to worse outcomes thn wht occurs in dily prctice. STAR*D encourged ll ptients who did not chieve remission bsed on number to enter the next tril despite the filure of the QIDS/HRSD to differentilly weigh core depressive symptoms (e.g. mood, guilt, suicidl idetion, or nhedoni) nd ccessory ones (e.g. ppetite, insomni, or gittion) nd ptients self-ssessments of the reltive importnce of ech. p 277 Fifth, STAR*D s investigtors my hve overstted the benefits of remission reltive to ptients with merely substntil improvement s both groups hd high rtes of confirmed relpse during follow-up nd STAR*D s symptom-driven pursuit of more ggressive tretment ws not shown to be better thn usul cre. More importntly, by encourging PCPs whose ptients chieve merely substntil improvement from one AD to switching drugs or dding new drugs to the regimen 16, p 57 in their pursuit of less thn 8 HRSD score, STAR*D s investigtors fil to cknowledge the risks tht cme with ech such chnge; tht is, the step-by-step incresing rtes of drug intolernce nd study drop out. The mnner in which STAR*D s nlyses were conducted nd results communicted hve creted nrrtive round its ggressive tret-to-remission model of mesurement-bsed cre tht is not ligned with the ctul results of the study.
5 The STAR*D Tril: It Is Time to Reexmine the Clinicl Beliefs Tht Guide the Tretment of Mjor Depression STAR*D ws filed tril with results tht were not shown to be superior to tretment-s-usul. Despite this lck of evidence though, some STAR*D investigtors continue to dvocte strongly for the superiority of their mesurementbsed model of cre even rguing for the doption of finncil incentives nd 9 other policy chnges to mke it the stndrd-of-cre for psychitric prctice. 20 The STAR*D dt set re now vilble from NIMH for independent nlysis by university-bsed reserchers. 21 Reserchers re urged to request this dt set for independent nlysis of the steps 1 to 4 nd follow-up outcomes ccording to STAR*D s prespecified criteri. Only then will the lessons lerned from this once-in--genertion study be fully known nd mde vilble to inform clinicl prctice nd guide subsequent reserch efforts to improve on the sme. Acknowledgements In the pst 3 yers, Dr Pigott hs consulted for Amen Clinics, CNS Response, nd the Interntionl Society of Neurofeedbck nd Reserch. He lso owns stock options in CNS Response, compny tht mrkets quntittive electroencephlogrm dtbse to predict mediction response, nd is prtner in Positive Brin Trining, LLC, neurofeedbck prctice. He ffirms tht the mnuscript is n honest, ccurte, nd trnsprent ccount of his nlysis of wht he hs derived from the STAR*D investigtors published tbles nd figures reporting their findings nd then compring them to the Reserch Protocol he obtined from NIMH through the Freedom of Informtion Act. Editor s Note References 22 nd 23 cn be found in etble 1. References 1. Trivedi MH, Rush AJ, Wisniewski SR, et l. Evlution of outcomes with citloprm for depression using mesurement-bsed cre in STAR*D: implictions for clinicl prctice. Am J Psychitry. 2006;163: Fv M, Rush AJ, Trivedi MH, et l. Bckground nd rtionle for the Sequenced Tretment Alterntives to Relieve Depression (STAR*D) study. Psychitr Clin North Am. 2003;26: Rush AJ, Trivedi MH, Wisniewski SR, et l. Bupropion-SR, sertrline, or venlfxine-xr fter filure of SSRIs for depression. N Engl J Med. 2006;354: Trivedi MH, Fv M, Wisniewski SR, et l. Mediction ugmenttion fter the filure of SSRIs for depression. N Engl J Med. 2006;354: Rush AJ, Trivedi MH, Wisniewski SR, et l. Acute nd longer-term outcomes in depressed outptients requiring one or severl tretment steps: STAR*D report. Am J Psychitry. 2006;163: Trivedi MH, Stegmn D, Rush AJ, et l. STAR*D clinicl procedures mnul [Internet]. Pittsburgh (PA): University of Pittsburgh; 2002 Jul 31 [dte cited unknown]. Avilble from: 7. Pigott HE, Leventhl AM, Alter GS, et l. Efficcy nd effectiveness of ntidepressnts: current sttus of reserch. Psychother Psychosom. 2010;79: Pigott HE. STAR*D: tle nd tril of bis. Ethicl Hum Psychol Psychitry. 2011;13(1): Ntionl Institute of Mentl Helth (NIMH). Sequenced Tretment Alterntives to Relieve Depression (STAR*D) reserch protocol. Revised ed. Wshington (DC): NIMH; Received October 1, 2010, from NIMH following request under the Freedom of Informtion Act. Also vilble from: com/wp-content/uplods/2011/12/star-d%20protocol%20 with%20anlytic%20pln.pdf. 10. Greden JF. Workplce depression: personlize, prtner, or py the price. Am J Psychitry. 2013;170: Brbui C, Furukw TA, Ciprini A. Effectiveness of proxetine in the tretment of cute mjor depression in dults: systemtic re-exmintion of published nd unpublished dt from rndomized trils. CMAJ. 2008;178: Fv M, Rush AJ, Wisniewski SR, et l. A comprison of mirtzpine nd nortriptyline following two consecutive filed mediction tretments for depressed outptients: STAR*D report. Am J Psychitry. 2006;163: Nierenberg AA, Fv M, Trivedi MH, et l. A comprison of lithium nd T3 ugmenttion following two filed mediction tretments for depression: STAR*D report. Am J Psychitry. 2006;163: McGrth PJ, Stewrt JW, Fv M, et l. Trnylcypromine versus venlfxine plus mirtzpine following three filed ntidepressnt medictions trils for depression: STAR*D report. Am J Psychitry. 2006;163: Trivedi MH, Morris DW, Wisniewski SR, et l. Increse in work productivity of depressed individuls with improvement in depressive symptom severity. Am J Psychitry. 2013;170: Gynes BN, Rush AJ, Trivedi MH, et l. The STAR*D study: treting depression in the rel world. Clev Clin J Med. 2008;75: Morris DW, Trivedi MH. Mesurement-bsed cre for unipolr depression. Curr Psychitry Rep. 2011;13(6): Shelton RC, Trivedi MH. Using lgorithms nd computerized decision support systems to tret mjor depression. J Clin Psychitry. 2011;72(12):e Trivedi MH. Evluting nd monitoring tretment response in depression using mesurement-bsed ssessment nd rting scles. J Clin Psychitry. 2013;74(7):e Hrding KJ, Rush AJ, Arbuckle M, et l. Mesurement-bsed cre in psychitric prctice: policy frmework for implementtion. J Clin Psychitry. 2011;72(8): Ntionl Institute of Mentl Helth (NIMH). Avilble limited ccess dtsets from NIMH clinicl trils: Sequenced Tretment Alterntives to Relieve Depression (STAR*D). Wshington (DC): NIMH; [yer of publiction unknown] [cited 2013 Aug 26]. Avilble from: imh-procedures-for-requesting-dt-sets.shtml. 22. Ntionl Institute of Mentl Helth (NIMH). New strtegies help depressed ptients become symptom-free [Internet]. Wshington (DC): NIMH; 2006 [cited 2013 Aug 26]. Avilble from: Hmilton M. Development of rting scle for primry depressive illness. Br J Soc Clin Psychol. 1967;6: The Cndin Journl of Psychitry, Vol 60, No 1, Jnury 2015 W 13
Supplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationAddendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)
Addendum to the Evidence Review Group Report on Aripiprzole for the tretment of schizophreni in dolescents (ged 15-17 yers) Produced by Authors Correspondence to Southmpton Helth Technology Assessments
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationNonpharmacologic Interventions for Treatment-Resistant Depression in Adults Executive Summary
Comprtive Effectiveness Review Numer 33 Effective Helth Cre Progrm Nonphrmcologic Interventions for Tretment-Resistnt Depression in Adults Executive Summry Bckground Mjor depressive disorder (MDD) is common
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationReducing the Risk. Logic Model
Reducing the Risk Logic Model ETR (Eduction, Trining nd Reserch) is nonprofit orgniztion committed to providing science-bsed innovtive solutions in helth nd eduction designed to chieve trnsformtive chnge
More informationManagement and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence
Clinicin Summry Mentl Helth Eting Disorders Mngement nd Outcomes of Binge-Eting Disorder in Adults: Current Stte of the Evidence Focus of This Summry This is summry of systemtic review evluting the evidence
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationSummary. Effect evaluation of the Rehabilitation of Drug-Addicted Offenders Act (SOV)
Summry Effect evlution of the Rehbilittion of Drug-Addicted Offenders Act (SOV) The Rehbilittion of Drug-Addicted Offenders Act (SOV) ws lunched on April first 2001. This lw permitted the compulsory plcement
More informationY. Yazici 1, D. Moniz Reed 2, C. Klem 2, L. Rosenblatt 2, G. Wu 2, J.M. Kremer 3
Greter remission rtes in ptients with erly versus long-stnding disese in biologic-nive rheumtoid rthritis ptients treted with btcept: post hoc nlysis of rndomised clinicl tril dt Y. Yzici 1, D. Moniz Reed
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationHealth-Related Quality of Life and Symptoms of Depression in Extremely Obese Persons Seeking Bariatric Surgery
Oesity Surgery, 15, 3-39 Helth-Relted Qulity of Life nd Symptoms of Depression in Extremely Oese Persons Seeking Britric Surgery Anthony N. Frictore, PhD; Thoms A. Wdden, PhD; Dvid B. Srwer, PhD; Myles
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationHealth Coaching: A Preliminary Report on the Effects in Traumatic Brain Injury/Polytrauma Patients
ORIGINAL RESEARCH Helth Coching: A Preliminry Report on the Effects in Trumtic Brin Injury/Polytrum Ptients Esmerld Mdrigl, MSW; Mx Gry, BA; Molly A. Timmermn, DO; Ttin Orozco, PhD; Dine Cowper Ripley,
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationEvaluation of a task-oriented client-centered upper extremity skilled performance training module in persons with tetraplegia
(2011) 49, 1049 1054 & 2011 Interntionl Society All rights reserved 1362-4393/11 $32.00 www.nture.com/sc ORIGINAL ARTICLE Evlution of tsk-oriented client-centered upper extremity skilled performnce trining
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationInadequate health literacy is a
Testing the BRIEF Helth Litercy Screening Tool Jolie Hun, PhD, Virgini Nolnd-Dodd, PhD, MPH, Jill Vrnes, EdD, John Grhm-Pole, MD, Brbr Rienzo, PhD, nd Ptrici Donldson, RN Due to the oppressive strins lid
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationQuantifying perceived impact of scientific publications
Quntifying perceived impct of scientific publictions Filippo Rdicchi, Alexnder Weissmn, nd John Bollen Center for Complex Networks nd Systems Reserch, School of Informtics nd Computing, Indin University,
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationPotential for Interactions Between Dietary Supplements and Prescription Medications a
CLINICAL RESEARCH STUDY Potentil for Interctions Between Dietry Supplements nd Prescription Medictions Amit Sood, MD, MSc, Rich Sood, MD, b Frncis J. Brinker, ND, Rvneet Mnn, MBBS, c Lur L. Loehrer, Dietlind
More information2. Hubs and authorities, a more detailed evaluation of the importance of Web pages using a variant of
5 Web Serch Outline: 1. Pge rnk, for discovering the most ëimportnt" pges on the Web, s used in Google. 2. Hubs nd uthorities, more detiled evlution of the importnce of Web pges using vrint of the eigenvector
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationFat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
Originl ppers Ft intke in ptients newly dignosed with type 2 dibetes: 4-yer follow-up study in generl prctice Floris A vn de Lr, Eloy H vn de Lisdonk, Peter L B J Lucssen, J M H Tigchelr, Sski Meyboom,
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationGoal: Evaluate plant health effects while suppressing dollar spot and brown patch
Newer Fungicide Products Alone nd In Rottion on Chicgo Golf Green Reserchers: Chicgo District Golf Assoc. Derek Settle, Tim Sibicky, nd Nick DeVries Gol: Evlute plnt helth effects while suppressing dollr
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationMental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes
Fmily Prctice, 2015, Vol. 32, No. 3, 317 322 doi:10.1093/fmpr/cmv014 Advnce Access publiction 5 April 2015 Helth Service Reserch Mentl helth symptoms nd ptient-reported dibetes symptom burden: implictions
More informationPilot Trial of Osteopathic Manipulative Therapy for Patients With Frequent Episodic Tension-Type Headache
Pilot Tril of Osteopthic Mnipultive Therpy for Ptients With Frequent Episodic Tension-Type Hedche Guido Rolle, MD, DO (Itly); Lucio Tremolizzo, MD, PhD; Frncesco Somlvico, MS; Crlo Ferrrese, MD, PhD; nd
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationEffect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationA Four-System Comparison of Patients With Chronic Illness: The Military Health System, Veterans Health Administration, Medicaid, and Commercial Plans
MILITARY MEDICINE, 174, 9:936, 2009 A Four-System Comprison of Ptients With Chronic Illness: The Militry Helth System, Veterns Helth Administrtion, Medicid, nd Commercil Plns Teres B. Gibson, PhD * ; Todd
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationPrime Enrollees Consumer Watch NHC Patuxent River FY 2016 Defense Health Cost Assessment & Program Evaluation
Prime Enrollees Consumer Wtch NHC Ptuxent River 16 Defense Helth Cost Assessment & Progrm Evlution NHC Ptuxent River: Smple size-1,457 Response rte-1.2% Source: Helth Cre Survey of DoD Beneficiries Inside
More informationORIGINAL ARTICLE. Diagnostic Signs of Accommodative Insufficiency. PILAR CACHO, OD, ÁNGEL GARCÍA, OD, FRANCISCO LARA, OD, and M A MAR SEGUÍ, OD
1040-5488/02/7909-0614/0 VOL. 79, NO. 9, PP. 614 620 OPTOMETRY AND VISION SCIENCE Copyright 2002 Americn Acdemy of Optometry ORIGINAL ARTICLE Dignostic Signs of Accommodtive Insufficiency PILAR CACHO,
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationTHE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS
THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS John F. Ptience nd Doug Gillis SUMMARY
More informationThe Acute Time Course of Concurrent Activation Potentiation
Mrquette University e-publictions@mrquette Exercise Science Fculty Reserch nd Publictions Exercise Science, Deprtment of 1-1-2010 The Acute Time Course of Concurrent Activtion Potentition Luke Grceu Mrquette
More informationIn the treatment of cardiovascular disease (CVD), national
n report n Beyond LDL Cholesterol: The Role of Elevted Triglycerides nd Low HDL Cholesterol in Residul CVD Risk Remining After Sttin Therpy Peter Algon Jr, MD, FACC In the tretment of crdiovsculr disese
More informationResearch Article Patterns of Cancer Genetic Testing: A Randomized Survey of Oregon Clinicians
Hindwi Publishing Corportion Journl of Cncer Epidemiology Volume 2012, Article ID 294730, 11 pges doi:10.1155/2012/294730 Reserch Article Ptterns of Cncer Genetic Testing: A Rndomized Survey of Oregon
More informationFactors influencing help seeking in mentally distressed young adults: a cross-sectional survey
L Biddle, D Gunnell, D Shrp nd J L Donovn Fctors influencing help seeking in mentlly distressed young dults: cross-sectionl survey Lucy Biddle, Dvid Gunnell, Debbie Shrp nd Jenny L Donovn SUMMARY Bckground:
More informationIn 2006, the prevalence of bipolar
With Bipolr Disorder Annette M. Mtthews, MD; Vness B. Wilson, BA; Suznne H. Mitchell, PhD; nd Peter Huser, MD This study of smoking ehviors nd smoking chrcteristics in veterns with ipolr disorder contriutes
More informationDebra A. Ignaut, R.N., B.S., C.D.E., and Haoda Fu, Ph.D.
Journl of Dietes Science nd Technology Volume 6, Issue 2, Mrch 2012 Dietes Technology Society TECHNOLOGY REPORT Comprison of Insulin Diluent Lekge Postinjection Using Two Different Needle Lengths nd Injection
More informationMecadox. Improves pig performance in a wide range of health and growing conditions. (Carbadox) Talk With a Phibro Expert:
SWINE (Crbdox) Improves pig performnce in wide rnge of helth nd growing conditions The Advntge Over the yers, medicted feed dditive hs proven to be cost-effective mngement tool for improving pig performnce
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More informationSeasonal influenza vaccination programme country profile: Ireland
Sesonl influenz vccintion progrmme country profile: Irelnd 2012 13 Seson Bckground informtion Influenz immunistion policy nd generl fcts bout Irelnd Volume indices of GDP per cpit in 2011 nd 2013 (EU-
More informationYaghoob Vakili 1,* ; Banafsheh Gharaee 2 ; Mojtaba Habibi Background
Irn J Psychitry Behv Sci. 2015 June; 9(2):e845. Published online 2015 June 1. DOI: 10.17795/ijpbs845 Originl Article Acceptnce nd Commitment Therpy, Selective Serotonin Reuptke Inhibitors, nd Their Combintion
More informationAppendix J Environmental Justice Populations
Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:
More informationChilblains (pernio, perniosis) are cold-induced, painful or itching
Nifedipine vs Plcebo for Tretment of Chronic Chilblins: A Rndomized Controlled Tril Ibo H. Souwer, MD 1 Jcobus H. J. Bor, BSc (Mth) 2 Pul Smits, MD, PhD 3 Antoine L. M. Lgro-Jnssen, MD, PhD 1 1 Deprtment
More informationURINARY incontinence is an important and common
Urinry incontinence in older people in the community: neglected problem? Helen Stoddrt, Jenny Donovn, Elise Whitley, Deborh Shrp nd In Hrvey SUMMARY Bckground: The prevlence nd impct of urinry incontinence
More informationEstimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain
Rpid communictions Estimting the impct of the influenz pndemic on mortlity in the elderly in Nvrre, Spin J Cstill (jcstilc@nvrr.es) 1, J Etxeberri 1, E Ardnz 1, Y Floristán 1, R López Escudero 1, M Guevr
More informationComputer-Aided Learning in Insulin Pump Training
Journl of Dibetes Science nd Technology Volume 4, Issue 4, July 2010 Dibetes Technology Society TECHNOLOGY REPORTS Computer-Aided Lerning in Insulin Pump Trining Sergey V., M.Sc., 1 nd Chrles J. George,
More informationSEIZURES AND EPILEPSY
SEIZURES AND EPILEPSY CONTENT CREATED BY Lern more t www.helth.hrvrd.edu TALK WITH YOUR DOCTOR Tble of Contents WHAT IS A SEIZURE? 4 WHAT IS EPILEPSY? 6 TESTING 7 TREATMENT OPTIONS 9 ANTI-SEIZURE MEDICATION
More informationSoybean Hulls as an Alternative Feed for Horses
Animl Industry Report AS 650 ASL R1931 2004 Soyben Hulls s n Alterntive Feed for Horses Josie Booth Iow Stte University Howrd Tyler Iow Stte University Peggy Miller-Auwerd Iow Stte University Jenette Moore
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationPhysicians prescribing a new medication often fail to discuss basic. Intervention to Enhance Communication About Newly Prescribed Medications
to Enhnce Communiction About Newly Prescribed Medictions Derjung M. Trn, MD, PhD 1 Debor A. Pterniti, PhD 2 Deborh K. Orosz, BA 3 Chi-Hong Tseng, PhD 4 Neil S. Wenger, MD, MPH 4 1 Deprtment of Fmily Medicine,
More informationMaximize Your Genetic Return. Find your Genetic Solution with Boviteq West
Mximize Your Genetic Return. Find your Genetic Solution with Boviteq West Boviteq West is comprehensive reproductive solutions provider, imed t finding the right genetic solution for every niml nd every
More informationEstimated Prevalence and Economic Burden of Severe, Uncontrolled Asthma in the United States
Estimted Prevlence nd Economic Burden of Severe, Uncontrolled Asthm in the United Sttes Cheryl S. Hnkin 1 ; Amy Bronstone 1 ; Zhohui Wng 1 ; Mry Butti-Smll 2 ; Philip O. Buck 2 1 BioMedEcon, Moss Bech,
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationThe Quality and Outcomes Framework (QOF) is a pay-for-performance
Effect of UK Py-for-Performnce Progrm on Ethnic Disprities in Dibetes Outcomes: Interrupted Time Series Anlysis Riydh Alshmsn, MSc John Tyu Lee, MSc Azeem Mjeed, MD Goplkrishnn Netuveli, PhD Christopher
More informationBariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI,35 kg/m 2
924 Dibetes Cre Volume 39, June 2016 METABOLIC SURGERY Britric/Metbolic Surgery to Tret Type 2 Dibetes in Ptients With BMI,35 kg/m 2 Dibetes Cre 2016;39:924 933 DOI: 10.2337/dc16-0350 Dvid E. Cummings
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationAgilent G6825AA MassHunter Pathways to PCDL Software Quick Start Guide
Agilent G6825AA MssHunter Pthwys to PCDL Softwre Quick Strt Guide Wht is Agilent Pthwys to PCDL? Fetures of Pthwys to PCDL Agilent MssHunter Pthwys to PCDL converter is stnd-lone softwre designed to fcilitte
More informationPosttraumatic stress disorder (PTSD), anxiety, and depression
Cost-Effectiveness of Collbortive Cre for Depression nd PTSD in Militry Personnel Tr A. Lvelle, PhD; Mllik Kommreddi, MPH; Lis H. Jycox, PhD; Brdley Belsher, PhD; Michel C. Freed, PhD; nd Chrles C. Engel,
More informationMay 28, Congressional Requesters
United Sttes Government Accountbility Office Wshington, DC 20548 My 28, 2010 Congressionl Requesters Subject: Federl Funds: Fiscl Yers 2002-2009 Obligtions, Disbursements, nd Expenditures for Selected
More informationPreliminary Findings of a Randomized Controlled Trial of an Interdisciplinary Military Pain Program
MILITARY MEDICINE, 174, 3:270, 2009 Preliminry Findings of Rndomized Controlled Tril of n Interdisciplinry Militry Pin Progrm Robert J. Gtchel, PhD * ; Donld D. McGery, PhD ; Aln Peterson, PhD ; Mysti
More informationEffect of Preoperative Intravenous Methocarbamol and Intravenous Acetaminophen on Opioid Use After Primary Total Hip and Knee Replacement
Feture Article Effect of Preopertive Intrvenous Methocrbmol nd Intrvenous Acetminophen on Opioid Use After Primry Totl Hip nd Knee Replcement THOMAS D. LOOKE, MD, PHD; CAMERON T. KLUTH, MBA bstrct Between
More informationECONOMIC EVALUATION OF WATER IODIZATION PROGRAM IN THAILAND
ECONOMIC EVALUATION OF WATER IODIZATION PROGRAM IN THAILAND CS Pndv 1, K Annd 1, Sngsom Sinwt 2 nd FU Ahmed 1 1 IDD Study Group, All Indi Institute of Medicl Sciences, New Delhi, Indi; 2 Division of Nutrition,
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationkey words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization
reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,
More informationWORKSHOP FOR SYRIA. A SHORT TERM PROJECT A Collaborative Map proposal Al Moadamyeh, Syria
Al Modmyeh is city locted south-west Dmscus, in Syri. It is fcing post-conflict sitution, fter yers of siege nd displcement of its inhbitnts. Now, the popultion is coming bck, s lso new incomers. Therefore,
More informationJOB DESCRIPTION. Volunteer Student Teacher. Warwick in Africa Programme. Warwick in Africa Programme Director
JOB DSCRIPTION POST TITL: DPARTMNT: POST RSPONSIBL TO: SALARY: Volunteer Student Techer Wrwick in Afric Progrmme Wrwick in Afric Progrmme Director Voluntry position, ll your costs will be covered (flights,
More informationWork-related musculoskeletal disorders (WMSDs) among nursing personnel
Work-Relted Musculoskeletl Injuries nd Disorders Among Occuptionl nd Physicl Therpists Amy R. Drrgh, Wendy Huddleston, Phyllis King KEY WORDS ccidents, occuptionl moving nd lifting ptients musculoskeletl
More informationReview TEACHING FOR GENERALIZATION & MAINTENANCE
Gols By the end of clss, you should be ble to: Explin wht generliztion is, why it is criticl for techers to know how to tech so tht it occurs, nd give n exmple of it from your own experience in the clssroom
More informationSuicide is the third leading cause of death in adolescents
Article Clinicl nd Psychosocil Predictors of Suicide Attempts nd Nonsuicidl Self-Injury in the Adolescent Depression Antidepressnts nd Psychotherpy Tril (ADAPT) Pul Wilkinson, M.D., M.R.C.Psych. Rphel
More informationbuild Firm, sexy arms
w uild Firm, sexy rms Wnt toned, strong rms tht crown you pushup queen t oot cmp? Wnt to rock tnk top? These four moves re wht you need. Achieve Totl Arm Envy Mny women zero in on the show-off muscles,
More informationA Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
ORIGINAL CONTRIBUTIONS 3 see relted editoril on pge x A Rndomized Phse III Clinicl Tril of Plecntide, Urogunylin Anlog, in Ptients With Chronic Idiopthic Constiption Philip B. Miner Jr, MD, Willim D. Koltun,
More informationAbstract. 1/15 PMCID: PMC
Prim Cre Compnion CNS Disord. 2012; 14(4): PCC.11m01296. Published online 2012 Jul 5. doi: 10.4088/PCC.11m01296 PMCID: PMC3505126 Eszopiclone Tretment for Insomni: Effect Size Comprisons in Ptients With
More informationMETHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY
METHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY 1.0 SCOPE AND APPLICATION 1.1 Method 4010 is procedure for screening solids such s soils, sludges, nd queous medi such s wste wter nd lechtes
More informationText Messaging for Psychiatric Outpatients Effect on Help-Seeking and Self-Harming Behaviors
2016 Shutterstock.com/zf Ern Contct Hours Text Messging for Psychitric Outptients Effect on Help-Seeking nd Self-Hrming Behviors Toyohiko Kodm, RN, MS; Hiroko Syouji, RN, MS; Schiko Tkki, RN, MS; Hirokzu
More informationJournal of Personality
T5r 19c2,4-J uytie& çln 0 Journl of Personlity EDTORAL BOARD GORDON W. ALLPORT Hrvrd University MERTON GLL Austen Riggs Foundtion JOHN GLLN University of North Crolin DONALD. HEBB McGill University DAVD
More informationLifetime and 12-Month Prevalence of Psychiatric Disorders in 8,169 Male Vietnam War Era Veterans
MILITARY MEDICINE, 169, 11:896, 2004 Lifetime nd 12-Month Prevlence of Psychitric Disorders in 8,169 Mle Vietnm Wr Er Veterns Gurntor: Seth A. Eisen, MD Contributors: Seth A. Eisen, MD* ; Kristin H. Griffith,
More informationLarry Alphs 1*, Cynthia A Bossie 1, Jennifer K Sliwa 1, Yi-Wen Ma 2 and Norris Turner 1. Abstract
PRIMARY RESEARCH Open Access Onset of efficcy with cute long-cting injectble pliperidone plmitte tretment in mrkedly to severely ill ptients with schizophreni: post hoc nlysis of rndomized, double-blind
More informationDXA: Can It Be Used as a Criterion Reference for Body Fat Measurements in Children?
nture publishing group rticles methods AND techniques DXA: Cn It Be Used s Criterion Reference for Body Ft Mesurements in Children? Romn J. Shypilo 1, Nncy F. Butte 1 nd Kenneth J. Ellis 1 Objective: Dul-energy
More information